Global pharma major Lupin Limited (Lupin) announced the launch of diazepam rectal gel, 10 mg and 20 mg, rectal delivery system, after its wholly owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey received an approval for its ANDA from the United States Food and Drug Administration (FDA).
Diazepam rectal gel, 10 mg and 20 mg, rectal delivery system is the generic version of Diastat AcuDial rectal delivery system, 10 mg and 20 mg, of Bausch Health US, LLC.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
